Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 7,639 More Arrow 8,454 Less Arrow 7,345
Financial expenses 1 Less Arrow 0 More Arrow 30
Earnings before taxes 4,502 More Arrow 4,949 Less Arrow 1,873
Total assets 65,142 Less Arrow 64,679 Less Arrow 62,777
Current assets 21,707 Less Arrow 20,239 Less Arrow 18,075
Current liabilities 4,842 Less Arrow 1,776 Less Arrow 1,594
Equity capital 60,000 More Arrow 62,561 Less Arrow 60,798
- share capital 19,862 More Arrow 21,209 More Arrow 22,385

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 92.1% More Arrow 96.7% More Arrow 96.8%
Turnover per employee
Profit as a percentage of turnover 58.9% Less Arrow 58.5% Less Arrow 25.5%
Return on assets (ROA) 6.9% More Arrow 7.7% Less Arrow 3.0%
Current ratio 448.3% More Arrow 1139.6% Less Arrow 1133.9%
Return on equity (ROE) 7.5% More Arrow 7.9% Less Arrow 3.1%
Change turnover -278 More Arrow 1,495 Less Arrow -829
Change turnover % -4% More Arrow 21% Less Arrow -10%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.